Back to
Danske Bank A/S
SEELQ
Showing 1 of 2 quarters
Position history for
Danske Bank A/S's holdings in SEELOS THERAPEUTICS INC
No. Danske Bank exited its SEELQ (Seelos Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 2 shares worth $8. Danske Bank first reported SEELQ in Q3 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SEELQ: Modera Wealth Management, LLC, UBS Group AG, Morgan Stanley, BlackRock, Inc., Bank of America Corp.